Biologics and Oral Small Molecules Are Not Associated With Increased Major Adverse Cardiovascular Events or Venous Thromboembolism in Inflammatory Bowel Disease Article (Web of Science) Early Access (Web of Science)

cited authors

  • Qapaja, Thabet; Abu-Rumaileh, Mohammed; Alsabbagh Alchirazi, Khaled; Gharaibeh, Ahmad; Naser, Ahmad; Hamid, Osama; Alayan, Dina; Regueiro, Miguel

publication date

  • November 13, 2024

webpage

published in

category

keywords

  • biologics
  • inflammatory bowel disease
  • major adverse cardiovascular events
  • oral small molecules
  • venous thromboembolism